[1]
O. Donaboyev, “The Role of Immuno-Genetic Biomarkers in Assessing the Effectiveness of Antirheumatic Therapy in Late-Stage Rheumatoid Arthritis”, FGS, vol. 3, no. 1, pp. 54–56, Jun. 2025.